IN2013MU01330A - - Google Patents

Info

Publication number
IN2013MU01330A
IN2013MU01330A IN1330MU2013A IN2013MU01330A IN 2013MU01330 A IN2013MU01330 A IN 2013MU01330A IN 1330MU2013 A IN1330MU2013 A IN 1330MU2013A IN 2013MU01330 A IN2013MU01330 A IN 2013MU01330A
Authority
IN
India
Prior art keywords
vitamin
lysine
oral
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
Other languages
English (en)
Inventor
Venkata Sivakumar Bobba
Pramod Tripathi Alok
Dadasaheb Pol Shankar
Original Assignee
Getz Pharma Res Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Getz Pharma Res Pvt Ltd filed Critical Getz Pharma Res Pvt Ltd
Priority to IN1330MU2013 priority Critical patent/IN2013MU01330A/en
Publication of IN2013MU01330A publication Critical patent/IN2013MU01330A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1330MU2013 2013-04-08 2013-04-08 IN2013MU01330A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1330MU2013 IN2013MU01330A (fr) 2013-04-08 2013-04-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1330MU2013 IN2013MU01330A (fr) 2013-04-08 2013-04-08

Publications (1)

Publication Number Publication Date
IN2013MU01330A true IN2013MU01330A (fr) 2015-04-10

Family

ID=54395759

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1330MU2013 IN2013MU01330A (fr) 2013-04-08 2013-04-08

Country Status (1)

Country Link
IN (1) IN2013MU01330A (fr)

Similar Documents

Publication Publication Date Title
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
MX351584B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
PH12015501096A1 (en) Composition for immediate and extended release
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
TN2015000135A1 (en) Modified release formulations for oprozomib
BR112014014795A2 (pt) sistema de pélete de multiunidade de liberação imediata
PL3003383T3 (pl) Stała kompozycja do podawania doustnego zawierająca kwas ibandronowy lub jego farmaceutycznie dopuszczalną sól i witaminę d
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
MX355719B (es) Composicion farmaceutica en forma de una suspension oral que comprende una fraccion flavonoica y goma de xantano.
MX370184B (es) Composición farmacéutica que comprende fingolimod.
IN2013MU01330A (fr)
IN2013CH04314A (fr)
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida
PH12018501487A1 (en) Galenic formulation comprising a topical drug
MX2015011099A (es) Composiciones farmaceuticas de donepezilo que tienen un perfil de disolución in vitro o parámetros farmacocinéticos específicos.
MX2015013279A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.
IN2013MU03123A (fr)
UA80559U (ru) Паста варченко для лечения заболеваний пародонта и слизистой оболочки полости рта
MX2013003022A (es) Composiciones farmaceuticas de montelukast y levocetirizina.
IN2013MU02059A (fr)
IN2013MU03656A (fr)